CME
59
3
ED
39
8
ECL
54
5
MAS
46
3
OXY
42
17
MAT
41
2
A
43
2
SO
48
6
SJM
17
5
MA
60
5
UPS
51
6
PH
60
5
EMC
30
-26
NEE
39
9
GWW
50
9
D
32
10
PDCO
77
3
MSI
52
3
MDLZ
28
2
SRE
37
9
CME
59
3
ED
39
8
ECL
54
5
MAS
46
3
OXY
42
17
MAT
41
2
A
43
2
SO
48
6
SJM
17
5
MA
60
5
UPS
51
6
PH
60
5
EMC
30
-26
NEE
39
9
GWW
50
9
D
32
10
PDCO
77
3
MSI
52
3
MDLZ
28
2
SRE
37
9
Financhill
Back

OncoCyte Vs. Novo Nordisk AS Industry Stock Comparison

Sell
21

OCX
OncoCyte

Last Price:
$2.23
Seasonality Move:
11.63%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
21
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.21. The Score for OCX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 30.62 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.28 - 2.6) Sell
Bollinger Bands (100): (2.6 - 3.18) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.27 Sell
20-day SMA: 2.39 Sell
50-day SMA: 2.73 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.27 Sell
20-day EMA: 2.4 Sell
50-day EMA: 2.63 Sell
200-day EMA: 3.06 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):